Karo Pharma receives approval to delist the Company's share from Nasdaq Stockholm in connection with the change of listing venue to Nasdaq First North Growth Market

HUDDINGE, Sweden, March 10, 2022 /PRNewswire/ -- Karo Pharma Aktiebolag (publ) (the "Company" or "Karo Pharma") announced in a press release on 9 March 2022 that Karo Pharma's Board of Directors

Related Keywords

Sweden ,Stockholm ,Huddinge ,Karo Pharma ,Christoffer Lorenzen ,Jon Johnsson ,Prnewswire Karo Pharma Aktiebolag ,Company Or Karo Pharma , ,Pharma Aktiebolag ,Nasdaq Stockholm ,Nasdaq Stockholm First North Growth Market ,Nasdaq First North Growth ,Nasdaq First North Growth Market ,Nasdaq Stockholm Large ,Bokaro ,Dharma ,Eceives ,Approval ,Relist ,Company ,Phare ,Rom ,Nasdaq ,Connection ,Change ,Listing ,Revenue ,First ,North ,Growth ,Market ,